Reversible myopathy after statin therapy in patients with normal creatine kinase levels [2] (multiple letters)

Annals of Internal Medicine

Volumn 138, Issue 5, 2003, Pages 436-437

  Bennett, William E ^a   Drake III, Almond J ^a   Mohamed Shakir, K M ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CREATINE KINASE BLOOD LEVEL; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; HUMAN; HYPERCHOLESTEROLEMIA; LETTER; MUSCLE CRAMP; MUSCLE WEAKNESS; MYOPATHY; PATIENT MONITORING; PRIORITY JOURNAL; RHABDOMYOLYSIS;

EID: 0037418542     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-138-5-200303040-00021     Document Type: Letter

References (2)

1. Phillips PS, Haas RH, Bannykh S, Hathaway S, Gray NL, Kimura BJ, et al. Statin-associated myopathy with normal creatine kinase levels. Ann Intern Med. 2002;137: 581-5. [PMID: 12353945]
2. Boger RH. Drug interactions of the statins and consequences for drug selection. Int J Clin Pharmacol Ther. 2001;39:369-82. [PMID: 11563683]